Who are treatments for essential tremor's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Propofol induced sedation, Propofol-based total intravenous anesthesia, Stiripentol Oral Capsule, Auris-Sedina, propofol (drug), The midazolam ketamine group.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/treatments-for-essential-tremor.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

treatments for essential tremor — Competitive Intelligence Brief

treatments for essential tremor (treatments for essential tremor) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: GABA_A receptor modulator. Area: Neurology.

phase 3 GABA_A receptor modulator GABA_A receptor Neurology Small molecule Live · refreshed every 30 min

Target snapshot

treatments for essential tremor (treatments for essential tremor) — US Department of Veterans Affairs. This drug targets the GABA_A receptor to modulate neuronal excitability.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
treatments for essential tremor TARGET	treatments for essential tremor	US Department of Veterans Affairs	phase 3	GABA_A receptor modulator	GABA_A receptor
Propofol induced sedation	Propofol induced sedation	Centre Hospitalier Universitaire de Saint Etienne	phase 3	GABA_A receptor agonist	GABA_A receptor
Propofol-based total intravenous anesthesia	Propofol-based total intravenous anesthesia	The Cleveland Clinic	phase 3	GABA_A receptor agonist	GABA_A receptor
Stiripentol Oral Capsule	Stiripentol Oral Capsule	Biocodex	phase 3	GABA_A receptor modulator	GABA_A receptor
Auris-Sedina	Auris-Sedina	Laboratorios Osorio de Moraes Ltda.	phase 3	Benzodiazepine	GABA_A receptor
propofol (drug)	propofol (drug)	B. Braun Melsungen AG	phase 3	GABA receptor agonist	GABA_A receptor
The midazolam ketamine group	The midazolam ketamine group	Kasr El Aini Hospital	phase 3	Benzodiazepine and NMDA receptor antagonist	GABA_A receptor, NMDA receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (GABA_A receptor modulator class)

Biocodex · 1 drug in this class
BrainCells Inc. · 1 drug in this class
US Department of Veterans Affairs · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). treatments for essential tremor — Competitive Intelligence Brief. https://druglandscape.com/ci/treatments-for-essential-tremor. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab